Aoxing Pharmaceutical Company Inc Share Price Nyse
Equities
US03740A1060
Pharmaceuticals
Sales 2015 | 2.55Cr 212.13Cr | Sales 2016 | 3.23Cr 269.14Cr | Capitalization | 4.95Cr 412.39Cr |
---|---|---|---|---|---|
Net income 2015 | 50L 42Cr | Net income 2016 | 20L 17Cr | EV / Sales 2015 | 5.77 x |
Net Debt 2015 | 2.48Cr 206.5Cr | Net Debt 2016 | 1.86Cr 154.51Cr | EV / Sales 2016 | 2.11 x |
P/E ratio 2015 |
20.1
x | P/E ratio 2016 |
23.2
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11/23/11 |
Gui Rong Zhou
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/11/01 |
Peng Jiang
SAM | Sales & Marketing | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Duarte
CEO | Chief Executive Officer | - | 11/23/11 |
1st Jan change | Capi. | |
---|---|---|
+22.35% | 4.41TCr | |
+22.22% | 2.26TCr | |
+17.81% | 1.51TCr | |
+15.73% | 1.36TCr | |
+57.91% | 1.33TCr | |
-8.98% | 693.96Cr | |
-0.05% | 678.76Cr | |
+15.65% | 575.2Cr | |
-8.87% | 572.55Cr |